Cambridge Investment Research Advisors »

Aikido Pharma shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Aikido Pharma (DOMH) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Aikido Pharma

Tip: Access up to 7 years of quarterly data

All positions including Aikido Pharma held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aikido Pharma by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $100k 20k 4.96

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Alphabet Inc Cap Stk Cl C (GOOG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Aikido Pharma

Vanguard Group
Citadel Advisors
Connective Capital Management
BlackRock
Two Sigma Investments
Geode Capital Management
Renaissance Technologies
Jane Street
State Street Corporation
Two Sigma Advisers
Millennium Management
Cambridge Investment Research Advisors
Northern Trust
Dimensional Fund Advisors
KKM Financial

View all funds holding Aikido Pharma